gastrointestinal tumour
Conditions
Interventions
Experimental group:Provide nutritional support to Jiashan Jialichang
Control Group:Provide nutritional support
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who need to receive enteral nutrition support and undergo gastrointestinal tumor surgery; 2. Aged 18 to 75 years; 3. BMI 18.5-28.0 kg/m2 (inclusive) on admission; 4. APACHE-II score = 7 days; 6. Sign the informed consent form voluntarily, and complete the questionnaire survey and follow-up as required; when it is impossible to sign the informed consent form and complete the questionnaire survey and follow-up visit, the legal representative or guardian can act on his behalf.
Exclusion criteria
Exclusion criteria: 1. BMI 28.0 kg/m2; 2. Unable to establish enteral nutrition pathway; 3. Presence of hemodynamic instability, gastrointestinal bleeding, postoperative acute pancreatitis, inflammatory bowel disease (Crohn's disease or ulcerative colitis), intestinal ischemia, persistent intestinal obstruction, intestinal paralysis, high flow Patients with enteral nutrition contraindications such as intestinal atrophy and inability to establish remote access; 4. Patients with infectious diarrhea; 5. Bone marrow or organ transplant patients; 6. Other patients with leukopenia, neutropenia, malignant blood diseases, HIV and other clinically deemed unsuitable to participate in this study; 7. Patients with renal insufficiency (eGFR < 60mL/min), or patients requiring dialysis treatment; 8. Thyroid dysfunction; 9. The patient himself, legal representative or guardian refuses to participate in the researcher; 10. Pregnant or lactating female patients; 11. Those who are known to be allergic to any of the ingredients in the research or control products, or those who need to limit dietary fiber intake in the judgment of the investigator; 12. Galactosemia; 13. Expected survival <= 10 days.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Peripheral blood immune indicators; | — |
Countries
China
Contacts
Public ContactWu Xiaoting
West China Hospital, Sichuan University
Outcome results
None listed